High Risk Does Not Translate to High Benefit From Extended Endocrine Therapy
Dr. Naughton recognizes the difference between risk of recurrence and likelihood of benefit from extended endocrine therapy, noting the two do not always correlate, as they can be based on separate bi... Author: BreastCancerIndex Added: 12/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 4, 2015 Category: Cancer & Oncology Source Type: podcasts

Personalizing Cancer Care Beyond 5 Years
Previously, risk reduction from treatment with endocrine therapy has been represented as a general percentage for all patients treated. Knowing that in reality each patient responds differently, Dr. ... Author: BreastCancerIndex Added: 10/30/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2015 Category: Cancer & Oncology Source Type: podcasts

Endocrine therapy for early stage breast cancer is not benign
Dr. Naughton discusses the bothersome side effects and serious safety risks associated with endocrine therapy. He emphasizes the need to weigh patient benefit versus the impact on quality of life due... Author: BreastCancerIndex Added: 10/15/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 16, 2015 Category: Cancer & Oncology Source Type: podcasts

Extend or End Endocrine Therapy After Year 5
BCI is a molecular, gene expression-based test uniquely positioned to identify patients best suited for extended endocrine treatment. It is the only validated, commercially available test that provide... Author: BreastCancerIndex Added: 07/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2015 Category: Cancer & Oncology Source Type: podcasts

Extend or End Endocrine Therapy After Year 5
BCI is a molecular, gene expression-based test uniquely positioned to identify patients best suited for extended endocrine treatment. It is the only validated, commercially available test that provide... Author: BreastCancerIndex Added: 06/24/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 24, 2015 Category: Cancer & Oncology Source Type: podcasts

@OncEd presents Advances in Early Breast Cancer with Dr. Maureen Trudeau
Advances in Early Breast Cancer (Chemotherapy and Targeted Therapy as well as Endocrine Therapy) are discussed by Dr. Maureen Trudeau from Sunnybrook Cancer Centre, Toronto, Canada Author: oncologyeducation Added: 02/09/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 9, 2015 Category: Cancer & Oncology Source Type: podcasts

Julie R. Gralow, MD: New Endocrine Therapy For Metastatic Breast Cancer
Dr. Julie Gralow sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a four-part interview. This is the first in the four-par... Author: vitaloptions Added: 02/25/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 26, 2013 Category: Cancer & Oncology Source Type: podcasts